These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23276997)

  • 41. New Experimental and Computational Tools for Drug Discovery: Medicinal Chemistry, Personalized Medicine, Ethical & Legal Issues - Part-V.
    Arrasate S; Duardo-Sánchez A; De Miguel Beriain I; Casabona CR; González-Díaz H
    Curr Top Med Chem; 2018; 18(25):2141-2142. PubMed ID: 30698106
    [No Abstract]   [Full Text] [Related]  

  • 42. Medicinal chemistry in drug discovery in big pharma: past, present and future.
    Campbell IB; Macdonald SJF; Procopiou PA
    Drug Discov Today; 2018 Feb; 23(2):219-234. PubMed ID: 29031621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The evolution of drug design at Merck Research Laboratories.
    Brown FK; Sherer EC; Johnson SA; Holloway MK; Sherborne BS
    J Comput Aided Mol Des; 2017 Mar; 31(3):255-266. PubMed ID: 27878643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An overview of aldehyde oxidase: an enzyme of emerging importance in novel drug discovery.
    Rashidi MR; Soltani S
    Expert Opin Drug Discov; 2017 Mar; 12(3):305-316. PubMed ID: 28095715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breaking the data barrier in computational medicinal chemistry.
    Schneider G
    Future Med Chem; 2014 Mar; 6(3):245-6. PubMed ID: 24575959
    [No Abstract]   [Full Text] [Related]  

  • 46. Alpine drug discovery summit: 10th Swiss Course on Medicinal Chemistry.
    Müller G; Ernst B
    ChemMedChem; 2012 Dec; 7(12):2237-40. PubMed ID: 23180615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global medicinal chemistry and GPCR conference: interview with Stevan Djuric.
    Djuric S
    Future Med Chem; 2018 Apr; 10(8):837-838. PubMed ID: 29580099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular topology as a novel approach for drug discovery.
    Gálvez J; Gálvez-Llompart M; García-Domenech R
    Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Global patent overview of Ginkgo biloba preparation].
    Cheng XM; Lei HM; Liu W
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(17):2889-93. PubMed ID: 24380318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A data mining method to facilitate SAR transfer.
    Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated decision support for assessing chemical liabilities.
    Spjuth O; Eklund M; Ahlberg Helgee E; Boyer S; Carlsson L
    J Chem Inf Model; 2011 Aug; 51(8):1840-7. PubMed ID: 21774475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Special issue: multi-criteria approaches in computer-aided drug discovery.
    Cruz-Monteagudo M
    Mini Rev Med Chem; 2012 Sep; 12(10):905-6. PubMed ID: 22974402
    [No Abstract]   [Full Text] [Related]  

  • 53. The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
    Wang T; Yuan XS; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2017 Aug; 12(8):769-784. PubMed ID: 28562095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enabling drug discovery project decisions with integrated computational chemistry and informatics.
    Tsui V; Ortwine DF; Blaney JM
    J Comput Aided Mol Des; 2017 Mar; 31(3):287-291. PubMed ID: 27796615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design of an activity landscape view taking compound-based feature probabilities into account.
    Zhang B; Vogt M; Bajorath J
    J Comput Aided Mol Des; 2014 Sep; 28(9):919-26. PubMed ID: 25001923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Applying medicinal chemistry transformations and multiparameter optimization to guide the search for high-quality leads and candidates.
    Segall M; Champness E; Leeding C; Lilien R; Mettu R; Stevens B
    J Chem Inf Model; 2011 Nov; 51(11):2967-76. PubMed ID: 21981548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of
    Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R
    Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists.
    Bonnet P
    Eur J Med Chem; 2012 Aug; 54():679-89. PubMed ID: 22749644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compounds.
    Marrero-Ponce Y; Casañola-Martín GM; Khan MT; Torrens F; Rescigno A; Abad C
    Curr Pharm Des; 2010; 16(24):2601-24. PubMed ID: 20642427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Computational techniques for diversity analysis and compound classification.
    Kitchen DB; Stahura FL; Bajorath J
    Mini Rev Med Chem; 2004 Dec; 4(10):1029-39. PubMed ID: 15579111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.